No results for ‘’
Sudarshan Pharma Industries Ltd
₹34.19
(4.97%)
Mon, 25 May 2026, 06:03 pm
Health Technology
Pharmaceuticals: Major
24.5KSudarshan Pharma Industries Return on Equity (ROE) History
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 10.19 | 15.66 | 46.34 |
| Price to book ratio | 0 | 0 | 0 | 1.33 | 1.60 | 5.59 |
| Price to sales ratio | 0 | 0 | 0 | 0.16 | 0.39 | 1.46 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 0 | 0 | 0 | 880.07M | 2.78B | 9.03B |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 5.82 | 12.09 | 22.26 |
| Debt to equity ratio | 1.05 | 1.32 | 1.03 | 0.34 | 0.94 | 1.30 |
| Return on equity % | 0 | 12.62 | 20.08 | 10.76 | 10.77 | 13.12 |
Sudarshan Pharma Industries Ltd Return on Equity
The Sudarshan Pharma Industries Ltd Return on Equity is a key financial metric used by investors to evaluate Sudarshan Pharma Industries Ltd's valuation, profitability, and overall financial performance. Tracking the Sudarshan Pharma Industries Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Sudarshan Pharma Industries Ltd (NSE: , BSE: 543828) is currently trading at ₹34.19, with a market capitalization of ₹7.84B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Sudarshan Pharma Industries Ltd Return on Equity is essential for fundamental analysis.
Sudarshan Pharma Industries Ltd Return on Equity Current Value
The current Sudarshan Pharma Industries Ltd Return on Equity stands at 13.12.
The latest Sudarshan Pharma Industries Ltd Return on Equity has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Sudarshan Pharma Industries Ltd Return on Equity Historical Trend
The Sudarshan Pharma Industries Ltd Return on Equity has shown the following historical trend:
- 2024: 13.12
- 2023: 10.77
- 2022: 10.76
- 2021: 20.08
- 2020: 12.62
The recent rise in Sudarshan Pharma Industries Ltd Return on Equity suggests strengthening valuation trends and improving market sentiment.
What Sudarshan Pharma Industries Ltd Return on Equity Indicates for Investors
The Sudarshan Pharma Industries Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Sudarshan Pharma Industries Ltd Return on Equity Analysis Summary
The Sudarshan Pharma Industries Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Sudarshan Pharma Industries Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Sudarshan Pharma Industries Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.